Experts who reviewed the terminology associated with genitourinary tract symptoms related to menopause—currently referred to as vulvovaginal atrophy—have agreed that the term genitourinary syndrome of menopause (GSM) is a medically more accurate, all-encompassing, and a more publicly acceptable term. Their thoughts are published in a recent Journal of Sexual Medicine article.
Going forward, GSM will encompass a collection of symptoms and signs associated with a decrease in estrogen and other sex steroids and may include genital symptoms of dryness, burning, and irritation; sexual symptoms of lack of lubrication, discomfort or pain, and impaired function; and urinary symptoms of urgency, dysuria and recurrent urinary tract infections.
The Journal of Sexual Medicine